Potential Benefits of ETI Therapy for Non-CF Bronchiectasis with CFTR Dysfunction
Publisher：Unknown
·Published at: 2025-12-13
Discussion regarding how elexacaftor/tezacaftor/ivacaftor (ETI) therapy might benefit patients diagnosed with non-cystic fibrosis bronchiectasis who exhibit CFTR dysfunction.
Loading...